Management of Leptomeningeal Metastases in Non-oncogene Addicted Non-small Cell Lung Cancer
Brain metastases in non-small cell lung cancer (NSCLC) patients are more often detected due to imaging modalities improvements but also emerge because of improved treatments of the primary tumor which lead to a longer survival. In this context, development of leptomeningeal metastases (LM) is a deva...
Main Authors: | Ana Turkaj, Anna M. Morelli, Tiziana Vavalà, Silvia Novello |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2018.00278/full |
Similar Items
-
Ventriculoperitoneal Shunts Equipped with On-Off Valves for Intraventricular Therapies in Patients with Communicating Hydrocephalus due to Leptomeningeal Metastases
by: Michael C. Burger, et al.
Published: (2018-08-01) -
A Pilot Phase 1 Study of Intrathecal Pemetrexed for Refractory Leptomeningeal Metastases From Non-small-cell Lung Cancer
by: Zhenyu Pan, et al.
Published: (2019-08-01) -
Findings to Leptomeningeal Metastases in Lung Cancer: A Case Report
by: Thiago Rodrigo de Noronha, et al.
Published: (2019-01-01) -
A case report of endometrial adenocarcinoma with leptomeningeal metastases
by: Danial Fazilat‐Panah, et al.
Published: (2021-09-01) -
Research Progress of Lung Cancer with Leptomeningeal Metastasis
by: Chunhua MA, et al.
Published: (2014-09-01)